How Long Does It Take for Stereotactic Radiotherapy to Work

The answer is not immediate. And that can feel counterintuitive, especially when treatment itself may only take a few sessions. In reality, the effect of stereotactic radiotherapy develops gradually. It continues working long after the final treatment has been delivered.

What stereotactic radiotherapy actually does

Stereotactic radiotherapy, often referred to as SBRT or SABR, is a highly targeted form of radiation treatment.

It delivers very precise, high doses of radiation directly to the tumour while limiting exposure to surrounding healthy tissue. This allows treatment to be completed over a much shorter timeframe compared to conventional radiotherapy. In many cases, this involves between one and five sessions rather than several weeks.

But the key point is not just how quickly the treatment is delivered.

It is what happens afterwards.

Radiotherapy works by damaging the DNA of cancer cells. That damage does not cause the cells to die immediately. Instead, it prevents them from continuing to grow and divide. Over time, those damaged cells lose the ability to survive and are gradually cleared by the body.

When does it start to work?

The effects of stereotactic radiotherapy begin shortly after treatment, but they are not always visible straight away.

This is one of the areas that often causes confusion.

Cancer cells may begin to lose their ability to grow within days. However, it can take several weeks or even months before this becomes visible on scans. This delay is partly due to how the body processes damaged tissue, including inflammation and healing within the treated area.

In some cases, early imaging may appear unclear. The treated area can look inflamed or slightly larger before it stabilises or begins to shrink.

That does not mean the treatment has not worked.

It reflects the way the body responds to radiation.

How it works in lung cancer

In lung cancer, stereotactic radiotherapy is used in more specific situations.

It is often recommended for early-stage tumours, particularly when surgery is not suitable. It may also be used to treat small, well-defined areas of disease, including cases where the cancer has spread in a limited way.

What this means in practice is that the goal is highly focused. The aim is to treat a clearly defined tumour with precision, often with curative intent.

The response does not happen instantly. In most cases, the tumour will:

• stop growing first
• then gradually shrink over time
• or remain stable, which can still represent a successful outcome

For many patients with early-stage lung cancer, stereotactic radiotherapy can provide long-term control and, in many cases, cure.

This is where careful planning becomes essential. In more complex cases, this level of precision is delivered through a stereotactic radiotherapy treatment plan tailored to the tumour and surrounding structures, ensuring that treatment is both effective and as safe as possible.

What influences how quickly it works

Not every tumour responds at the same rate.

Several factors influence how quickly changes are seen:

• Tumour type and biology
• Size and location of the tumour
• Overall health and immune response
• Previous treatments

I mean, even two patients with similar scans can have very different response patterns.

Some tumours shrink quite quickly. Others take longer to show visible change, even when the treatment has been effective.

This is why follow-up imaging is carefully timed. Scans are usually performed at intervals to assess response rather than immediately after treatment.

What patients notice during this time

From a patient’s perspective, the experience can vary.

Some people notice an improvement in symptoms fairly quickly, particularly if the tumour was affecting breathing or causing discomfort.

Others may not feel a significant change in the early stages.

Fatigue is one of the more common side effects, although it is usually temporary. Some patients may also experience mild inflammation in the treated area, which can cause short-term symptoms before things settle.

What matters is that the treatment continues to work beneath the surface, even after the sessions have finished.

How this fits into the overall treatment plan

Stereotactic radiotherapy is not always used in isolation.

It forms part of a broader treatment strategy that may include surgery, chemotherapy, immunotherapy, or other forms of radiotherapy.

The decision to use it depends on several factors, including the stage of the disease, the position of the tumour, and the overall clinical picture.

This is where the process becomes more individualised. The goal is not simply to treat quickly, but to treat in a way that fits the situation as accurately as possible.

In more complex cases, particularly where timing and treatment selection are critical, this level of planning is often guided by a private oncology consultant.

Having access to that level of expertise can help ensure that treatment decisions are both timely and carefully considered.

The bigger picture

Stereotactic radiotherapy represents a shift in how radiotherapy is delivered.

Instead of spreading treatment over many weeks, it allows high doses to be delivered in a small number of sessions with a high degree of accuracy.

But the biological timeline remains the same.

Radiation works gradually. Cancer cells divide over time. It’s only when the cancer cell tries to divide after the radiotherapy damage that the cell dies. The body then responds and adapts.

So while the treatment itself may be brief, the effects develop over weeks and months.

Understanding that distinction helps set realistic expectations.

About Dr James Wilson

Understanding how quickly stereotactic radiotherapy works is part of making sense of the wider treatment process. Timing, response, and follow-up all play a role in how treatment is assessed.

Dr James Wilson is a consultant clinical oncologist specialising in lung cancer and advanced radiotherapy techniques. Based in full-time private practice in Central London, he focuses on delivering precise, carefully structured treatment plans, particularly when decisions require clarity, timing, and a high degree of clinical judgement.